MedPage Today: Combo Tx Offers ‘Salvage’ in Tough-to-Treat HCV

An investigational drug combination offers renewed hope of a cure for chronic hepatitis C (HCV) patients who have tried and failed therapy with the new direct-acting antiviral agents, a researcher said here.

Read the full story at MedPage Today



Share This Article!
Article Categories: In the News

Recent News